Register for streaming realtime charts, analysis tools, and prices.

Get Started

OCGN

Ocugen (OCGN)

Ocugen Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OCGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Date	Time	Source	Headline	Symbol	Company
07/11/2024	12:21PM	iHub Newswire	FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
11/02/2023	7:30AM	GlobeNewswire Inc.	Ocugen to Host Conference Call on Thursday, November 9 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2023 Financial Results	NASDAQ:OCGN	Ocugen Inc
10/10/2023	9:05AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCGN	Ocugen Inc
10/10/2023	6:30AM	GlobeNewswire Inc.	Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials	NASDAQ:OCGN	Ocugen Inc
10/04/2023	7:00AM	GlobeNewswire Inc.	Ocugen to Present at the 2023 Cell & Gene Meeting on the Mesa	NASDAQ:OCGN	Ocugen Inc
09/29/2023	7:30AM	GlobeNewswire Inc.	Ocugen CSO to Participate in 4th Annual Gene Therapy for Ophthalmic Disorders Conference	NASDAQ:OCGN	Ocugen Inc
09/27/2023	7:30PM	GlobeNewswire Inc.	Ocugen to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference	NASDAQ:OCGN	Ocugen Inc
09/21/2023	7:30AM	GlobeNewswire Inc.	Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board	NASDAQ:OCGN	Ocugen Inc
09/20/2023	8:00AM	GlobeNewswire Inc.	Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023	NASDAQ:OCGN	Ocugen Inc
09/19/2023	4:54PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCGN	Ocugen Inc
09/19/2023	4:01PM	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:OCGN	Ocugen Inc
09/13/2023	8:28AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCGN	Ocugen Inc
09/13/2023	8:15AM	GlobeNewswire Inc.	Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)	NASDAQ:OCGN	Ocugen Inc
09/12/2023	7:30PM	GlobeNewswire Inc.	Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023	NASDAQ:OCGN	Ocugen Inc
08/22/2023	9:12AM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCGN	Ocugen Inc
08/21/2023	4:48PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCGN	Ocugen Inc
08/21/2023	4:32PM	GlobeNewswire Inc.	Ocugen Provides Business Update with Second Quarter 2023 Financial Results	NASDAQ:OCGN	Ocugen Inc
08/21/2023	4:30PM	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:OCGN	Ocugen Inc
08/18/2023	4:39PM	GlobeNewswire Inc.	Ocugen to Host Conference Call on Tuesday, August 22 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2023 Financial Results	NASDAQ:OCGN	Ocugen Inc
08/15/2023	4:03PM	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:OCGN	Ocugen Inc
08/15/2023	4:01PM	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:OCGN	Ocugen Inc
06/30/2023	8:00AM	GlobeNewswire Inc.	Ocugen CEO & CSO to Present at 41st Annual AAPI Convention and Scientific Assembly	NASDAQ:OCGN	Ocugen Inc
06/21/2023	4:30PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:OCGN	Ocugen Inc
06/20/2023	4:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OCGN	Ocugen Inc
06/09/2023	5:29PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OCGN	Ocugen Inc
06/09/2023	5:28PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OCGN	Ocugen Inc
06/09/2023	5:26PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OCGN	Ocugen Inc
06/09/2023	5:25PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OCGN	Ocugen Inc
06/09/2023	4:17PM	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:OCGN	Ocugen Inc
06/09/2023	4:05PM	GlobeNewswire Inc.	Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders	NASDAQ:OCGN	Ocugen Inc

Showing the most relevant articles for your search:NASDAQ:OCGN

<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 Next >>

Maxeon Solar Technologies

Good Vibrations Shoes (PK)

TPT Global Tech (PK)

Virexit Technologies (PK)

Moon Equity (PK)

Code Green Apparel (PK)

Brookmount Explorations (PK)

Branded Legacy (PK)

Net Savings Link (PK)

Asia Broadband (PK)

Delayed Upgrade Clock